Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Elevation Oncology, Inc. Common Stock, par value $0.0001 per share (ELEV).
- Disclosed ownership: 7%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 7% ownership in Elevation Oncology, Inc. Common Stock, par value $0.0001 per share (ELEV) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.9% | 2,374,712 | 0 | 2,374,712 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 3.9% | 2,374,712 | 0 | 2,374,712 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3% | 1,826,364 | 0 | 1,826,364 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3% | 1,826,364 | 0 | 1,826,364 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.4% | 210,388 | 0 | 210,388 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.4% | 210,388 | 0 | 210,388 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 6.6% | 4,201,076 | 0 | 4,201,076 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 7% | 4,440,000 | 0 | 4,440,000 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 7% | 4,440,000 | 0 | 4,440,000 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 7% | 4,440,000 | 0 | 4,440,000 | /s/ Mark N. Lampert | Mark N. Lampert |